NCT04221412No Longer Available不适用
JNJ-53718678 RSV Pre-Approval Access_Single Patient Access (SPR) for Patients Diagnosed With RSV
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
研究概览
简要总结
The purpose of this pre-approval access program is to provide treatment to immunocompromised participants with serious/life-threatening diseases or conditions (Respiratory Syncytial Virus [RSV] infection) and to collect the safety data to understand the safety profile of JNJ-53718678.
研究设计
- 研究类型
- Expanded Access
入排标准
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
No Longer Available
不适用
Pre-Approval Access to Pimodivir for the Treatment of Patients With H7N9 Influenza A InfectionH7N9 Subtype of Influenza A VirusNCT03834376Janssen Research & Development, LLC
Unknown
不适用
Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple MyelomaRelapsed or Refractory Multiple MyelomaNCT05503550Janssen Research & Development, LLC
Available
不适用
Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)Alopecia AreataNCT05522556Pfizer
Unknown
不适用
Pre-Approval Access to Esketamine Nasal Spray for the Treatment of Treatment-Resistant Depression (TRD)Depressive Disorder, Treatment-ResistantNCT03829579Janssen Research & Development, LLC
No Longer Available
不适用
Individual Patient Investigational New Drug (IND) Expanded Access Program of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Participant With Multiple MyelomaMultiple MyelomaNCT04452994Janssen Research & Development, LLC